Advertisement
Screener

LivaNova PLC (LIVN) Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent

2.8 / 5 stars · 68/120 Roast Me

LivaNova PLC Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent

LivaNova PLC (LIVN) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of -$86.25 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-27.

Discontinued › Income Statement › Net Income

us-gaap:IncomeLossFromContinuingOperations · last filed 2023-02-27

  • LivaNova PLC income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2021-12-31 was -$5.13M.
  • LivaNova PLC income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2021-09-30 was -$43.44M.
  • LivaNova PLC income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2021-06-30 was -$56.49M.
  • LivaNova PLC income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2021-03-31 was -$30.76M, a 182.13% decline year-over-year.
  • LivaNova PLC income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2022 was -$86.25M.
  • LivaNova PLC income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2021 was -$135.82M.
  • LivaNova PLC income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2020 was -$347.33M.
  • LivaNova PLC income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2019 was -$158.00M.
Period endIncome (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 monthIncome (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 month as first filedIncome (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 6 monthIncome (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 8 monthIncome (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 9 monthIncome (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 12 monthIncome (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 12 month as first filed
2022-12-31-$86.25M
10-K · filed 2023-02-27
2021-12-31-$5.13M
10-K · filed 2022-03-01
-$48.57M
derived: sum of 2 quarters · filed 2022-03-01
-$105.06M
derived: sum of 3 quarters · filed 2022-03-01
-$135.82M
10-K · filed 2023-02-27
2021-09-30-$43.44M
10-K · filed 2022-03-01
-$42.24M
10-Q · filed 2021-11-03
-$99.93M
derived: sum of 2 quarters · filed 2022-03-01
-$127.25M
10-Q · filed 2021-11-03
-$411.24M
derived: sum of 4 quarters · filed 2022-03-01
2021-06-30-$56.49M
10-K · filed 2022-03-01
-$55.32M
10-Q · filed 2021-07-28
-$85.02M
10-Q · filed 2021-07-28
-$367.80M
derived: sum of 3 quarters · filed 2022-03-01
-$382.61M
derived: sum of 4 quarters · filed 2022-03-01
2021-03-31-$30.76M
10-K · filed 2022-03-01
-$29.70M
10-Q · filed 2021-04-28
-$311.31M
derived: sum of 2 quarters · filed 2022-03-01
-$326.13M
derived: sum of 3 quarters · filed 2022-03-01
-$415.54M
derived: sum of 4 quarters · filed 2022-03-01
2020-12-31-$280.55M
10-K · filed 2022-03-01
-$295.37M
derived: sum of 2 quarters · filed 2022-03-01
-$384.78M
derived: sum of 3 quarters · filed 2022-03-01
-$347.33M
10-K · filed 2023-02-27
-$343.51M
10-K · filed 2021-03-01
2020-09-30-$14.81M
10-K · filed 2022-03-01
-$14.77M
10-Q · filed 2020-10-29
-$104.23M
derived: sum of 2 quarters · filed 2022-03-01
-$64.19M
10-Q · filed 2021-11-03
-$210.19M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$89.42M
10-K · filed 2022-03-01
-$87.99M
10-Q · filed 2020-07-29
-$49.41M
10-Q · filed 2021-07-28
-$195.38M
derived: sum of 3 quarters · filed 2022-03-01
-$163.26M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$37.45M
10-K · filed 2022-03-01
$38.58M
10-Q · filed 2020-04-30
-$105.96M
derived: sum of 2 quarters · filed 2022-03-01
-$73.84M
derived: sum of 3 quarters · filed 2022-03-01
-$103.24M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$143.42M
10-K · filed 2020-03-02
-$111.30M
derived: sum of 2 quarters · filed 2020-10-29
-$140.69M
derived: sum of 3 quarters · filed 2020-10-29
-$158.00M
10-K · filed 2022-03-01
-$155.54M
10-K · filed 2020-03-02
2019-09-30$32.12M
10-Q · filed 2020-10-29
$2.73M
derived: sum of 2 quarters · filed 2020-10-29
-$12.12M
10-Q · filed 2020-10-29
-$221.66M
derived: sum of 4 quarters · filed 2020-10-29
2019-06-30-$29.39M
10-Q · filed 2020-07-29
-$44.24M
10-Q · filed 2020-07-29
-$253.78M
derived: sum of 3 quarters · filed 2020-07-29
-$260.05M
derived: sum of 4 quarters · filed 2020-07-29
2019-03-31-$14.85M
10-Q · filed 2020-04-30
-$224.39M
derived: sum of 2 quarters · filed 2020-04-30
-$230.66M
derived: sum of 3 quarters · filed 2020-04-30
-$211.13M
derived: sum of 4 quarters · filed 2020-04-30
2018-12-31-$209.54M
10-K · filed 2020-03-02
-$215.81M
derived: sum of 2 quarters · filed 2020-03-02
-$196.28M
derived: sum of 3 quarters · filed 2020-03-02
-$178.46M
10-K · filed 2021-03-01
2018-09-30-$6.27M
10-K · filed 2020-03-02
$13.26M
derived: sum of 2 quarters · filed 2020-03-02
$31.08M
10-Q · filed 2019-10-30
-$379.00K
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$19.53M
10-K · filed 2020-03-02
$37.35M
10-Q · filed 2019-07-31
$5.89M
derived: sum of 3 quarters · filed 2020-03-02
$32.91M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$17.82M
10-K · filed 2020-03-02
-$13.63M
derived: sum of 2 quarters · filed 2020-03-02
$13.38M
derived: sum of 3 quarters · filed 2020-03-02
$59.06M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31-$31.46M
10-K · filed 2019-03-18
-$4.44M
derived: sum of 2 quarters · filed 2019-03-18
$41.24M
derived: sum of 3 quarters · filed 2019-03-18
$54.47M
10-K · filed 2020-03-02
2017-09-30$27.02M
10-K · filed 2019-03-18
$27.00M
10-K · filed 2018-02-28
$72.69M
derived: sum of 2 quarters · filed 2019-03-18
$85.92M
10-Q · filed 2018-11-01
$79.61M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30$45.68M
10-K · filed 2019-03-18
$45.69M
10-K · filed 2018-02-28
$58.91M
10-Q · filed 2018-08-02
$52.60M
derived: sum of 3 quarters · filed 2019-03-18
$59.03M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31$13.23M
10-K · filed 2019-03-18
$6.92M
derived: sum of 2 quarters · filed 2019-03-18
$13.35M
derived: sum of 3 quarters · filed 2019-03-18
$26.09M
derived: sum of 4 quarters · filed 2019-03-18
2016-12-31-$6.31M
10-K · filed 2018-02-28
$125.00K
derived: sum of 2 quarters · filed 2018-02-28
$12.86M
derived: sum of 3 quarters · filed 2018-02-28
$1.87M
10-K · filed 2019-03-18
2016-09-30$6.43M
10-K · filed 2018-02-28
$19.17M
derived: sum of 2 quarters · filed 2018-02-28
$8.18M
derived: sum of 3 quarters · filed 2018-02-28
2016-06-30$12.74M
10-K · filed 2018-02-28
$1.75M
derived: sum of 2 quarters · filed 2018-02-28
2016-03-31-$10.99M
10-K · filed 2018-02-28
2015-12-31-$14.72M
10-K · filed 2018-02-28
2015-04-24$57.85M
10-K · filed 2018-02-28
2014-12-26$35.07M
10-K · filed 2018-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Integer Holdings Corp (ITGR)United States$4.289B25.17
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53